A single centre experience in the use of superparamagnetic iron oxide as an alternative tracer in sentinel node biopsy in early breast cancer

Abstract

Sentinel lymph node biopsy using dual radioisotope and Patent Blue dye remains the gold standard in intraoperative assessment of the axilla in early breast cancer (1). However, difficulties exist in both the worldwide supply of Technetium (2) and its use in hospitals without an ARSAC license. With recent changes in delivery of breast cancer services, secondary to pressures from COVID-19, Original Article